{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:31:51Z","timestamp":1785461511340,"version":"3.56.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jocn.2012.05.048","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T23:31:04Z","timestamp":1362785464000},"page":"759-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tropical spastic paraparesis treated with Combivir (lamivudine\u2013zidovudine)"],"prefix":"10.1016","volume":"20","author":[{"given":"Syed","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Zervos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2012.05.048_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","article-title":"Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad","volume":"17","author":"Maloney","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jocn.2012.05.048_b0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/423957","article-title":"Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis","volume":"39","author":"Gotuzzo","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jocn.2012.05.048_b0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.urology.2007.01.052","article-title":"Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers","volume":"69","author":"Castro","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jocn.2012.05.048_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2008.01.004","article-title":"Corticosteroid therapy in TSP\/HAM patients: the results from a 10 years open cohort","volume":"269","author":"Croda","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2012.05.048_b0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ana.20429","article-title":"Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease","volume":"57","author":"Oh","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2012.05.048_b0030","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/aid.1991.7.1031","article-title":"Tropical spastic paraparesis\/HTLV-1-associated myelopathy (TSP\/HAM): treatment with an anabolic steroid danazol","volume":"7","author":"Harrington","year":"1991","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jocn.2012.05.048_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-3-63","article-title":"Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial","volume":"3","author":"Taylor","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.jocn.2012.05.048_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(01)00287-8","article-title":"The effect of antiretroviral therapy on HTLV infection","volume":"78","author":"Machuca","year":"2001","journal-title":"Virus Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812005188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586812005188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:16:50Z","timestamp":1760822210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586812005188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0967586812005188"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2012.05.048","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tropical spastic paraparesis treated with Combivir (lamivudine\u2013zidovudine)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2012.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}